Alinity m CMV
PMA P210022510(k) K243485
Active
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK243485 | Date1 Jul 2025 | StatusActive |
| United States | FDA PMA PMA | NumberP210022 | Date5 May 2022 | StatusActive |
Official records
- FDA 510(k) database K243485
- FDA PMA database P210022
From the FDA record
FDA PMA P210022
- Received by the FDA
- 8 Nov 2024
- FDA decision
- 1 Jul 2025 (Substantially Equivalent)
- FDA review time
- 235 days from receipt to decision
- Docket number
- 22M-0773
Approval for Alinity m CMV. Alinity m CMV AMP KitThe Alinity m CMV assay is an in vitro polymerase chain reaction (PCR) assay for use with the automated Alinity m System to quantitate cytomegalovirus (CMV) DNA in human EDTA plasma. The Alinity m CMV assay is intended for use as an aid in the management of Hematopoietic Stem Cell Transplant and Solid Organ Transplant patients who are undergoing anti-cytomegalovirus therapy. The Alinity m CMV assay can be used to assess virological response to anti-cytomegalovirus therapy. The results from the Alinity m CMV test must be interpreted within the context of all relevant clinical and laboratory findings. The Alinity m CMV test is not intended as a screening test for the presence of CMV DNA in blood or blood products.Alinity m CTRL KitThe Alinity m CMV controls are for validity determination of the quantitative Alinity m CMV assay on the automated Alinity m System. These controls are intended to be used with the Alinity m CMV assay; refer to the assay package insert for additional information.Alinity m CAL KitThe Alinity m CMV calibrators are for calibration for the Alinity m CMV assay on the automated Alinity m System when used for the quantitative determination of CMV DNA. The calibrators are intended to be used with the Alinity m CMV assay; refer to the assay package insert for additional information.
Across registries
- FDA 510(k) K243485 decided 1 Jul 2025 Active
- FDA PMA P210022 decided 5 May 2022 Active
Timeline
- Approved FDA PMA P210022
- Cleared FDA 510(k) K243485
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k), FDA PMA Active
Specification
- Generic name
- Cytomegalovirus (cmv) dna quantitative assay
- PMA number
- 510(k) Number
- FDA product code
- PAB
- Device class
- Class II
- Regulation
- 21 CFR Part 866.3180
- Advisory committee
- Microbiology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Alinity m CMV AMP Kit is an in vitro polymerase chain reaction (PCR) assay designed for quantitative detection of cytomegalovirus (CMV) DNA in human EDTA plasma. Classified as a microbiology device under FDA nomenclature, it is intended for use on the automated Alinity m System to aid in managing transplant patients undergoing anti-CMV therapy, including hematopoietic and solid organ transplant recipients.
The assay is supplied as a kit for use with the Alinity m System, including controls (Alinity m CTRL Kit) and calibrators (Alinity m CAL Kit) for validation and quantitative calibration. It is intended for single-use in clinical laboratory settings and has received FDA 510(k) and PMA authorizations. No MRI safety or sterility specifications are noted in the provided data.
Similar devices
Other devices filed under FDA product code PAB (Cytomegalovirus (Cmv) Dna Quantitative Assay).
- Aptima® CMV, CONTROLS KIT, APTIMA, IVD PRD-05076 by Hologic
- COBAS AMPLIPREP/ COBAS TAQMAN CMV TEST by Roche Molecular System, Inc.
- Aptima® KIT, MAIN ASSAY, CMV, 100-TEST, IVD ASY-12071 by Hologic
- cobas CMV Test by Roche Molecular System, Inc.
- Aptima CMV Quant Assay by Hologic, Inc.
- Artus CMV RGQ MDX Kit by Qiagen, Inc.